BNB$659.73-0.41%BRENT$93.43-0.38%BTC$74,563-0.25%COPPER$6.53+1.06%DJI$52,759-1.32%DOGE$0.0819-1.30%DXY98.72-0.17%ETH$2,346-0.03%GOLD$4,532+0.36%NDX$29,213-0.72%SILVER$68.79+1.05%SOL$89.29+0.02%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%BNB$659.73-0.41%BRENT$93.43-0.38%BTC$74,563-0.25%COPPER$6.53+1.06%DJI$52,759-1.32%DOGE$0.0819-1.30%DXY98.72-0.17%ETH$2,346-0.03%GOLD$4,532+0.36%NDX$29,213-0.72%SILVER$68.79+1.05%SOL$89.29+0.02%SPX$7,641-0.87%US10Y4.70+0.92%VIX16.01+7.52%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 75%

Bank of America Allocates $250 Million for GLP-1 Drugs

Key takeaways

  • Bank of America CEO reveals the bank spends $250 million annually on GLP-1 drugs for employees, highlighting rising demand for treatments like Ozempic and
#healthcare#pharmaceuticals#corporate spending

Analysis

Bank of America CEO reveals the bank spends $250 million annually on GLP-1 drugs for employees, highlighting rising demand for treatments like Ozempic and

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.